{{Rsnum
|rsid=135551
|Gene=PPARA
|Chromosome=22
|position=46157126
|Orientation=minus
|GMAF=0.2874
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PPARA
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 56.6 | 33.6 | 9.7
| HCB | 84.7 | 13.9 | 1.5
| JPT | 88.5 | 11.5 | 0.0
| YRI | 13.6 | 51.0 | 35.4
| ASW | 19.3 | 54.4 | 26.3
| CHB | 84.7 | 13.9 | 1.5
| CHD | 83.5 | 14.7 | 1.8
| GIH | 79.2 | 18.8 | 2.0
| LWK | 9.1 | 50.0 | 40.9
| MEX | 69.0 | 29.3 | 1.7
| MKK | 29.5 | 49.4 | 21.2
| TSI | 64.7 | 29.4 | 5.9
| HapMapRevision=28
}}{{PMID|18336366}} 667 cases and 862 controls (OR=0.87, P=0.046, 95% CI=0.72-0.99 for rs135551; OR=0.80, P=0.034, 95%  [[myocardial infarction]] in a European population.

{{PMID Auto
|PMID=21430558
|Title=Association of the peroxisome proliferator-activated receptor alpha gene L162V polymorphism with stage C heart failure.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}